Published in Int J Radiat Oncol Biol Phys on November 15, 2004
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys (2004) 2.16
Hypofractionation for prostate cancer. Cancer J (2009) 1.21
Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol (2008) 1.04
Hypofractionated external-beam radiotherapy for prostate cancer. Prostate Cancer (2013) 0.99
Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol (2011) 0.96
Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion. Strahlenther Onkol (2008) 0.95
Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer. J Exp Clin Cancer Res (2009) 0.94
Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding. Radiat Oncol (2009) 0.91
Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis. J Radiat Res (2014) 0.87
Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer. J Radiat Res (2013) 0.86
Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients. Rep Pract Oncol Radiother (2014) 0.82
Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer. Strahlenther Onkol (2009) 0.80
Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer. Br J Radiol (2015) 0.80
New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy. World J Stem Cells (2013) 0.80
Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer. Radiat Oncol (2006) 0.79
Current role of spacers for prostate cancer radiotherapy. World J Clin Oncol (2015) 0.76
Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications. Radiat Oncol (2016) 0.75
Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol (2016) 0.75
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report. J Med Case Rep (2014) 0.75
Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives. Cancer Manag Res (2017) 0.75
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1. Cancer Res (2013) 3.08
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 3.01
Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res (2009) 2.14
Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys (2012) 2.00
Bulk production of a new form of sp(2) carbon: crystalline graphene nanoribbons. Nano Lett (2008) 1.92
NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment. Mol Cell Biol (2006) 1.69
Immunological effects of silica and asbestos. Cell Mol Immunol (2007) 1.69
Intraoperative monitoring of visual evoked potential: introduction of a clinically useful method. J Neurosurg (2010) 1.67
Confirmation of blood flow in perforating arteries using fluorescein cerebral angiography during aneurysm surgery. J Neurosurg (2007) 1.66
Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma. J Thorac Oncol (2010) 1.56
Anatomical study of the lower-positioned transverse ligament. Br J Plast Surg (2004) 1.55
Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci (2011) 1.55
Myoneural junctions of extraocular muscles: distances from the orbital rim and widths. Ophthalmologica (2006) 1.53
Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci (2012) 1.49
Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys (2006) 1.49
Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908. Lung Cancer (2004) 1.48
Propofol induces growth cone collapse and neurite retractions in chick explant culture. Can J Anaesth (2006) 1.45
Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol (2009) 1.42
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study. Int J Urol (2013) 1.41
Discrimination of acute graft-versus-host disease from infections by enumeration of peripheral blood interferon-gamma spot-forming cells. Transplantation (2006) 1.41
DinB upregulation is the sole role of the SOS response in stress-induced mutagenesis in Escherichia coli. Genetics (2009) 1.40
Combined ascorbic acid and sodium nitrite treatment induces oxidative DNA damage-associated mutagenicity in vitro, but lacks initiation activity in rat forestomach epithelium. Toxicol Sci (2008) 1.40
Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Cancer Res (2012) 1.40
Fibrous connective tissue between Müller's muscle and the palpebral conjunctiva as a reinforcement structure and a natural barrier for the upper eyelid. Okajimas Folia Anat Jpn (2005) 1.38
Characterization of bundled and individual triple-walled carbon nanotubes by resonant Raman spectroscopy. ACS Nano (2013) 1.38
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Brachytherapy (2011) 1.38
Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. Jpn J Clin Oncol (2007) 1.34
Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun (2010) 1.32
An essential role of the aPKC-Aurora A-NDEL1 pathway in neurite elongation by modulation of microtubule dynamics. Nat Cell Biol (2009) 1.31
Nitrogen-doped graphene: beyond single substitution and enhanced molecular sensing. Sci Rep (2012) 1.31
The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol Cell Biol (2013) 1.30
Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer (2009) 1.25
Microscopic findings of lateral tarsal fixation in Asians. Ophthal Plast Reconstr Surg (2008) 1.24
Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol (2004) 1.22
The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort. J Cancer Res Clin Oncol (2013) 1.22
Role of a sentinel surveillance system in the context of global surveillance of infectious diseases. Lancet Infect Dis (2004) 1.21
Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate (2003) 1.19
Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol (2003) 1.18
Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. Virology (2011) 1.18
Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother (2013) 1.15
Vaccination coverage of poliomyelitis among less than 5-year-old children in the markets of Niger. Jpn J Infect Dis (2003) 1.15
Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett (2003) 1.13
PP2C family members play key roles in regulation of cell survival and apoptosis. Cancer Sci (2006) 1.13
The MARS feasibility trial: conclusions not supported by data. Lancet Oncol (2011) 1.13
CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy. J Radiat Res (2010) 1.12
A new improved method for the concentration of HIV-1 infective particles. J Virol Methods (2002) 1.11
Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer (2002) 1.11
The lacrimal canaliculus and sac bordered by the Horner's muscle form the functional lacrimal drainage system. Ophthalmology (2005) 1.11
Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion (2004) 1.10
Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol (2008) 1.10
Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol (2008) 1.09
Connective tissue configuration in the human liver hilar region with special reference to the liver capsule and vascular sheath. J Hepatobiliary Pancreat Surg (2008) 1.08
Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res (2005) 1.08
Endoscopic resection of gangliocytic paraganglioma of the minor duodenal papilla: case report and review. Gastrointest Endosc (2002) 1.08
Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys (2011) 1.07
Estimation of internal exposure of the thyroid to (131)I on the basis of (134)Cs accumulated in the body among evacuees of the Fukushima Daiichi Nuclear Power Station accident. Environ Int (2013) 1.06
No raphe identified in the orbicularis oculi muscle. Okajimas Folia Anat Jpn (2004) 1.05
Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol (2007) 1.05
Proposal for a new classification of variations in the iliac venous system based on internal iliac veins: a case series and a review of double and left inferior vena cava. Anat Sci Int (2013) 1.04
Inhibitory effect of green tea catechins in combination with sucralfate on Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol (2004) 1.04
Elemental fluorine. Part 16. Versatile thin-film gas-liquid multi-channel microreactors for effective scale-out. Lab Chip (2005) 1.04
Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results. PLoS One (2013) 1.04
Intracavitary combined with CT-guided interstitial brachytherapy for locally advanced uterine cervical cancer: introduction of the technique and a case presentation. J Radiat Res (2011) 1.03
Microscopic anatomy of Asian lower eyelids. Ophthal Plast Reconstr Surg (2006) 1.02
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam. Urology (2004) 1.02
The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res (2003) 1.02
Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis (2006) 1.02
Rapidly progressive malignant epithelioid angiomyolipoma of the kidney. J Urol (2002) 1.02
Chloride ions control the G1/S cell-cycle checkpoint by regulating the expression of p21 through a p53-independent pathway in human gastric cancer cells. Biochem Biophys Res Commun (2007) 1.02
High-dose-rate interstitial brachytherapy with computed tomography-based treatment planning for patients with locally advanced uterine cervical carcinoma. J Radiat Res (2011) 1.01
The lower eyelid retractor consists of definite double layers. Ophthalmology (2006) 1.01
A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci (2003) 1.00
Genomewide linkage analysis of familial prostate cancer in the Japanese population. J Hum Genet (2003) 1.00
Nuclear survivin expression predicts poorer prognosis in glioblastoma. J Neurooncol (2008) 1.00
Higher pAkt expression predicts a significant worse prognosis in glioblastomas. J Radiat Res (2010) 1.00
Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg (2004) 1.00
IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res (2008) 0.99
Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys (2006) 0.99
Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma. Respir Med (2010) 0.99
Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer. Cancer Sci (2010) 0.99
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys (2006) 0.99
Heavy-ion-induced bystander killing of human lung cancer cells: role of gap junctional intercellular communication. Cancer Sci (2009) 0.99
Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys (2005) 0.98
Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization. Int J Radiat Oncol Biol Phys (2006) 0.98
Overview of the lacrimal canaliculus in microscopic cross-section. Orbit (2007) 0.98